Nymox Pharmaceutical Corp (NYMX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 9k | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.07M | -1.78M | -1.48M | 1.68M | -1.39M | -1.1M | -1.01M | -5.29M |
| Pre Tax Income | -5.09M | 1.34M | -1.49M | -1.34M | -1.39M | -1.11M | -1.04M | -5.31M |
| Net Income | -5.09M | 1.34M | -1.49M | -1.34M | -1.39M | -1.11M | -1.04M | -5.31M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -5.07M | 1.33M | -1.48M | -1.32M | -1.39M | -1.1M | -1.01M | -5.29M |
| EBITDA | -5.07M | -1.78M | -1.48M | 1.69M | -1.38M | -987k | -973k | -5.44M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 283k | 224k | 299k | 116k | 5k | 0 | 0 | 0 |
| Operating Income | -12.87M | -13.24M | -10.64M | -13.33M | -11.72M | -12.5M | -6.65M | -8.79M |
| Pre Tax Income | -13.11M | -13.43M | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M | -8.84M |
| Net Income | -13.11M | -13.43M | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M | -8.84M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
| EBIT | -12.87M | -13.24M | -10.64M | -13.33M | -11.72M | -12.5M | -6.54M | -8.79M |
| EBITDA | -12.87M | -13.23M | -10.64M | -13.33M | -11.71M | -12.49M | -6.64M | -8.78M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
